Psychotherapy Enhancement for Therapeutic Community (TC) Retention - 1
Public ClinicalTrials.gov record NCT00086398. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Psychotherapy Enhancement for TC Retention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy of Dual Focus Schema Therapy in comparison to Individual Drug Counseling as 6-month manualized individual behavioral therapy enhancements to the orientation/early treatment process of Therapeutic Community (TC) residents.
Study identification
- NCT ID
- NCT00086398
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 15 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2001
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Nov 6, 2005
Started 2001
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| APT Residential Services Division | New Haven | Connecticut | 06519 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Substance-Related Disorders trials
Other public records listing Substance-Related Disorders. Sorted by last update posted; newest first. Not a recommendation.
- NCT06548490: GLP-1R Agonist Treatment for Opioid Use Disorder Recruiting
- NCT07725289: Clinician Practice Companion to Address Youth Substance Use Not yet recruiting
- NCT06676059: SMART-r: Substance Monitoring and Active Relapse Tracking Repository Recruiting
- NCT05400252: Whole Health in VA Mental Health: Omnis Salutis Active, not recruiting
- NCT06236100: Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program Recruiting
- NCT05054738: CRP and S&A for Inpatient Veterans Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00086398, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2005 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00086398 live on ClinicalTrials.gov.